Found: 13
Select item for more details and to access through your institution.
CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 1, p. e1, doi. 10.1016/j.clgc.2022.07.008
- By:
- Publication type:
- Article
Alterations of 3D acetabular and lower limb parameters in adolescent idiopathic scoliosis.
- Published in:
- European Spine Journal, 2020, v. 29, n. 8, p. 2010, doi. 10.1007/s00586-020-06397-5
- By:
- Publication type:
- Article
The use of mirabegron in neurogenic bladder: a systematic review.
- Published in:
- World Journal of Urology, 2020, v. 38, n. 10, p. 2435, doi. 10.1007/s00345-019-03040-x
- By:
- Publication type:
- Article
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 11, p. e2134330, doi. 10.1001/jamanetworkopen.2021.34330
- By:
- Publication type:
- Article
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10708-6
- By:
- Publication type:
- Article
Bladder instillation for urinary tract infection prevention in neurogenic bladder patients practicing clean intermittent catheterization: A systematic review.
- Published in:
- Urologia Journal, 2022, v. 89, n. 2, p. 261, doi. 10.1177/03915603211049883
- By:
- Publication type:
- Article
Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 7, p. 1455, doi. 10.1002/ijc.33708
- By:
- Publication type:
- Article
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
- Published in:
- Oncologist, 2024, v. 29, n. 8, p. 699, doi. 10.1093/oncolo/oyae072
- By:
- Publication type:
- Article
Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation (SD) of renal cell carcinoma (RCC).
- Published in:
- Oncologist, 2023, v. 28, p. S8, doi. 10.1093/oncolo/oyad216.012
- By:
- Publication type:
- Article
Characterization of the Cellular Origin and Oncogenic Mechanisms of Chromophobe Renal Cell Carcinoma (ChRCC) and Renal Oncocytic Neoplasms.
- Published in:
- Oncologist, 2023, v. 28, p. S7, doi. 10.1093/oncolo/oyad216.011
- By:
- Publication type:
- Article
Host immune signatures as predictors of response to immunotherapy-based regimens in patients with metastatic renal cell carcinoma (mRCC).
- Published in:
- Oncologist, 2023, v. 28, p. S4, doi. 10.1093/oncolo/oyad216.007
- By:
- Publication type:
- Article
First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape.
- Published in:
- Oncologist, 2022, v. 27, n. 2, p. 125, doi. 10.1093/oncolo/oyab056
- By:
- Publication type:
- Article
Comparison of outcomes for Hispanic and non‐Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 11, p. 2003, doi. 10.1002/cncr.35216
- By:
- Publication type:
- Article